An Overview of the Effects of Lithium on Alzheimer’s Disease: A Historical Perspective
Abstract
1. Introduction
2. The Journey of Lithium: From Discovery to Clinical Applications
3. The Modern Revival of Lithium
4. The Legacy of Lithium: From Therapeutic Validation to Approval
5. Broadening the Use of Lithium in Neurocognitive Functions
6. Lithium and Its Impact on Human Health
7. Managing Lithium: Therapeutic Index and Risk to Toxicity
8. Advancing Lithium Research Through Translational Studies
9. Exploring Lithium’s Neuroprotective Potential
10. Conclusions
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Bernard, A. Lithium. Handbook on the Toxicology of Metals; Elsevier: Amsterdam, The Netherlands, 2015; Volume 2, pp. 969–974. ISBN 978-0-444-59453-2. [Google Scholar]
- Lazarus, J.H.; Collard, K.J. Lithium—History and Pharmacology. In Endocrine and Metabolic Effects of Lithium; Lazarus, J.H., Collard, K.J., Eds.; Springer US: Boston, MA, USA, 1986; pp. 1–15. ISBN 978-1-4899-2016-4. [Google Scholar]
- Cousins, D.A.; Squarcina, L.; Boumezbeur, F.; Young, A.H.; Bellivier, F. Lithium: Past, Present, and Future. Lancet Psychiatry 2020, 7, 222–224. [Google Scholar] [CrossRef] [PubMed]
- Shorter, E. The History of Lithium Therapy. Bipolar Disord. 2009, 11, 4–9. [Google Scholar] [CrossRef] [PubMed]
- Johnson, F.N. The History of Lithium Therapy, 1st ed.; Palgrave Macmillan: London, UK, 1984; ISBN 978-1-349-07289-7. [Google Scholar]
- Airainer, M.; Seifert, R. Lithium, the Gold Standard Drug for Bipolar Disorder: Analysis of Current Clinical Studies. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2024, 397, 9723–9743. [Google Scholar] [CrossRef] [PubMed]
- Chagas, C.; Corrêa, T. As Contribuições Científicas de José Bonifácio e a Descoberta Do Lítio: Um Caminhar Pela História Da Ciência. Rev. Educ. Ciênc. Mat. 2017, 7, 201–212. [Google Scholar]
- Fountoulakis, K.N. Historical Perspective. In Bipolar Disorder: An Evidence-Based Guide to Manic Depression; Fountoulakis, K.N., Ed.; Springer: Berlin/Heidelberg, Germany, 2015; pp. 1–25. ISBN 978-3-642-37216-2. [Google Scholar]
- Garrod, A.B. The Nature and Treatment of Gout and Rheumatic Gout; Walton and Maberly: London, UK, 1859. [Google Scholar]
- Haig, A. The Uric Acid Diathesis. Br. Med. J. 1896, 2, 1746–1747. [Google Scholar] [CrossRef]
- Hammond, W.A. A Treatise on Diseases of the Nervous System. Appleton and Co.: New York, NY, USA, 1871; pp. 32–364. ISBN 0282051856. [Google Scholar]
- Schioldann, J. ’On periodical depressions and their pathogenesis’ by Carl Lange (1886). Hist. Psychiatry 2011, 22, 108–130. [Google Scholar] [CrossRef]
- Baldessarini, R.J.; Stephens, J.H. Lithium Carbonate for Affective Disorders. I. Clinical Pharmacology and Toxicology. Arch. Gen. Psychiatry 1970, 22, 72–77. [Google Scholar] [CrossRef]
- Culbreth, D.M. A Manual of Materia Medica and Pharmacology: Comprising All Organic and Inorganic Drugs Which Are or Have Been Official in the United States Pharmacopoeia, Together with Important Allied Species and Useful Synthetics, Especially Designed for Students of Pharmacy and Medicine, as Well as for Druggists, Pharmacists, and Physicians; Lea & Febiger: Philadelphia, PA, USA, 1906. [Google Scholar]
- Cade, J.F.; Malhi, G.S. Cade’s Lithium. Acta Neuropsychiatr. 2007, 19, 125–126. [Google Scholar] [CrossRef]
- Cade, J.F.J. Lithium Salts in the Treatment of Psychotic Excitement. Med. J. Aust. 1949, 2, 349–352. [Google Scholar] [CrossRef]
- Burrows, G.D.; Tiller, J.W. Cade’s Observation of the Antimanic Effect of Lithium and Early Australian Research. Aust. N. Z. J. Psychiatry 1999, 33, S27–S31. [Google Scholar] [CrossRef]
- Johnson, F.N. The Work of John Cade. In The History of Lithium Therapy; Palgrave Macmillan UK: London, UK, 1984; pp. 34–45. ISBN 978-1-349-07291-0. [Google Scholar]
- Noack, C.H.; Trautner, E.M. The Lithium Treatment of Maniacal Psychosis. Med. J. Aust. 1951, 2, 219–222. [Google Scholar] [CrossRef]
- Kline, N.S. Depression: Its Diagnosis and Treatment—Lithium: The History of Its Use in Psychiatry; Karger Medical and Scientific Publishers: Basel, Switzerland, 1969; ISBN 978-3-318-03958-0. [Google Scholar]
- Trautner, E.M.; Morris, R.; Noack, C.H.; Gershon, S. The excretion and retention of ingested lithium and its effect on the ionic balance of man. Med. J. Aust. 1955, 2, 280–291. [Google Scholar] [CrossRef]
- Schou, M.; Juel-Nielsen, N.; Stromgren, E.; Voldby, H. The Treatment of Manic Psychoses by the Administration of Lithium Salts. J. Neurol. Neurosurg. Psychiatry 1954, 17, 250–260. [Google Scholar] [CrossRef] [PubMed]
- Baastrup, P.C.; Schou, M. Lithium as a Prophylactic Agents. Its Effect against Recurrent Depressions and Manic-Depressive Psychosis. Arch. Gen. Psychiatry 1967, 16, 162–172. [Google Scholar] [CrossRef] [PubMed]
- Baastrup, P.C.; Poulsen, J.C.; Schou, M.; Thomsen, K.; Amdisen, A. Prophylactic lithium: Double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 1970, 296, 326–330. [Google Scholar] [CrossRef]
- Schou, M.; Amdisen, A.; Baastrup, P.C. The Practical Management of Lithium Treatment. Br. J. Psychiatry 1975, 76–84. [Google Scholar]
- Schou, M. Current Status of Lithium Therapy in Affective Disorders. Arq. Neuro-Psiquiatr. 1976, 34, 68–80. [Google Scholar] [CrossRef]
- Gershon, S.; Yuwiler, A. Lithium Ion: A Specific Psychopharmacological Approach to the Treatment of Mania. J. Neuropsychiatr. 1960, 1, 229–241. [Google Scholar]
- Gershon, S. Lithium: Its Role in Psychiatric Research and Treatment, 1st ed.; Plenum Press: New York, NY, USA, 1973; ISBN 978-0-306-30720-1. [Google Scholar]
- Johnson, G.; Gershon, S. Early North American Research on Lithium. Aust. N. Z. J. Psychiatry 1999, 33, S48–S53. [Google Scholar] [CrossRef]
- The Current Status of Lithium Therapy: Report of the APA Task Force. Am. J. Psychiatry 1975, 132, 977–1001. [CrossRef]
- Squire, L.R.; Judd, L.L.; Janowsky, D.S.; Huey, L.Y. Effects of Lithium Carbonate on Memory and Other Cognitive Functions. Am. J. Psychiatry 1980, 137, 1042–1046. [Google Scholar] [CrossRef]
- Reus, V.I.; Targum, S.D.; Weingartner, H.; Post, R.M. Effect of Lithium Carbonate on Memory Processes of Bipolar Affectively Ill Patients. Psychopharmacology 1979, 63, 39–42. [Google Scholar] [CrossRef]
- Kusumo, K.S.; Vaughan, M. Effects of Lithium Salts on Memory. Br. J. Psychiatry 1977, 131, 453–457. [Google Scholar] [CrossRef] [PubMed]
- Rybakowski, J.K. Effect of Lithium on Neurocognitive Functioning. Curr. Alzheimer Res. 2016, 13, 887–893. [Google Scholar] [CrossRef]
- Manchia, M.; Paribello, P.; Pinna, M.; Steardo, L.; Carpiniello, B.; Pinna, F.; Pisanu, C.; Squassina, A.; Hajek, T. Lithium and Its Effects: Does Dose Matter? Int. J. Bipolar Disord. 2024, 12, 23. [Google Scholar] [CrossRef] [PubMed]
- Gitlin, M.; Bauer, M. Lithium: Current State of the Art and Future Directions. Int. J. Bipolar Disord. 2024, 12, 40. [Google Scholar] [CrossRef] [PubMed]
- Williams, K.H.; Goldstein, G. Cognitive and Affective Responses to Lithium in Patients with Organic Brain Syndrome. Am. J. Psychiatry 1979, 136, 800–803. [Google Scholar] [CrossRef]
- Calil, H.M.; Zwicker, A.P.; Klepacz, S. The Effects of Lithium Carbonate on Healthy Volunteers: Mood Stabilization? Biol. Psychiatry 1990, 27, 711–722. [Google Scholar] [CrossRef]
- Clarke, N.A.; Procter, A.W.; Webster, M.T.; Francis, P.T.; Hodgkiss, A.D.; Bowen, D.M. Effect of Li+ Therapy and Site of Origin on Cerebrospinal Fluid Beta-Amyloid Precursor Protein Derivatives. Biochem. Soc. Trans. 1993, 21 Pt 3, 242S. [Google Scholar] [CrossRef]
- Grof, P. Sixty Years of Lithium Responders. Neuropsychobiology 2010, 62, 8–16. [Google Scholar] [CrossRef] [PubMed]
- Singulani, M.P.; Ferreira, A.F.F.; Figueroa, P.S.; Cuyul-Vásquez, I.; Talib, L.L.; Britto, L.R.; Forlenza, O.V. Lithium and Disease Modification: A Systematic Review and Meta-Analysis in Alzheimer’s and Parkinson’s Disease. Ageing Res. Rev. 2024, 95, 102231. [Google Scholar] [CrossRef] [PubMed]
- Almeida, O.P.; Singulani, M.P.; Ford, A.H.; Hackett, M.L.; Etherton-Beer, C.; Flicker, L.; Hankey, G.J.; De Paula, V.J.R.; Penteado, C.T.; Forlenza, O.V. Lithium and Stroke Recovery: A Systematic Review and Meta-Analysis of Stroke Models in Rodents and Human Data. Stroke 2022, 53, 2935–2944. [Google Scholar] [CrossRef] [PubMed]
- Nunes, M.A.; Viel, T.A.; Buck, H.S. Microdose Lithium Treatment Stabilized Cognitive Impairment in Patients with Alzheimer’s Disease. Curr. Alzheimer Res. 2013, 10, 104–107. [Google Scholar] [CrossRef] [PubMed]
- Iordache, A.M.; Voica, C.; Roba, C.; Nechita, C. Lithium Content and Its Nutritional Beneficence, Dietary Intake, and Impact on Human Health in Edibles from the Romanian Market. Foods 2024, 13, 592. [Google Scholar] [CrossRef]
- El-Mallakh, R.S. Ion Homeostasis and the Mechanism of Action of Lithium. Clin. Neurosci. Res. 2004, 4, 227–231. [Google Scholar] [CrossRef]
- Kakhki, S.; Ahmadi-Soleimani, S.M. Experimental Data on Lithium Salts: From Neuroprotection to Multi-Organ Complications. Life Sci. 2022, 306, 120811. [Google Scholar] [CrossRef]
- Schrauzer, G.N. Lithium: Occurrence, Dietary Intakes, Nutritional Essentiality. J. Am. Coll. Nutr. 2002, 21, 14–21. [Google Scholar] [CrossRef]
- Ramos, P.; Santos, A.; Pinto, E.; Pinto, N.R.; Mendes, R.; Magalhães, T.; Almeida, A. Alkali Metals Levels in the Human Brain Tissue: Anatomical Region Differences and Age-Related Changes. J. Trace Elem. Med. Biol. 2016, 38, 174–182. [Google Scholar] [CrossRef]
- Shen, Y.; Zhao, M.; Zhao, P.; Meng, L.; Zhang, Y.; Zhang, G.; Taishi, Y.; Sun, L. Molecular Mechanisms and Therapeutic Potential of Lithium in Alzheimer’s Disease: Repurposing an Old Class of Drugs. Front. Pharmacol. 2024, 15, 1408462. [Google Scholar] [CrossRef]
- Wesseloo, R.; Wierdsma, A.I.; van Kamp, I.L.; Munk-Olsen, T.; Hoogendijk, W.J.G.; Kushner, S.A.; Bergink, V. Lithium Dosing Strategies during Pregnancy and the Postpartum Period. Br. J. Psychiatry 2017, 211, 31–36. [Google Scholar] [CrossRef]
- Mohandas, E.; Rajmohan, V. Lithium Use in Special Populations. Indian J. Psychiatry 2007, 49, 211–218. [Google Scholar] [CrossRef] [PubMed]
- Tondo, L.; Alda, M.; Bauer, M.; Bergink, V.; Grof, P.; Hajek, T.; Lewitka, U.; Licht, R.W.; Manchia, M.; Müller-Oerlinghausen, B.; et al. Clinical Use of Lithium Salts: Guide for Users and Prescribers. Int. J. Bipolar Disord. 2019, 7, 16. [Google Scholar] [CrossRef]
- Puglisi-Allegra, S.; Ruggieri, S.; Fornai, F. Translational Evidence for Lithium-Induced Brain Plasticity and Neuroprotection in the Treatment of Neuropsychiatric Disorders. Transl. Psychiatry 2021, 11, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Gogoleva, I.V.; Gromova, O.A.; Torshin, I.Y.; Grishina, T.R.; Pronin, A.V. The Neurobiological Role of Lithium Salts. Neurosci. Behav. Physi 2023, 53, 939–945. [Google Scholar] [CrossRef]
- Patel, S.; Yenush, L.; Rodríguez, P.L.; Serrano, R.; Blundell, T.L. Crystal Structure of an Enzyme Displaying Both Inositol-Polyphosphate-1-Phosphatase and 3′-Phosphoadenosine-5′-Phosphate Phosphatase Activities: A Novel Target of Lithium Therapy. J. Mol. Biol. 2002, 315, 677–685. [Google Scholar] [CrossRef]
- Sarkar, S.; Floto, R.A.; Berger, Z.; Imarisio, S.; Cordenier, A.; Pasco, M.; Cook, L.J.; Rubinsztein, D.C. Lithium Induces Autophagy by Inhibiting Inositol Monophosphatase. J. Cell Biol. 2005, 170, 1101–1111. [Google Scholar] [CrossRef]
- Singulani, M.P.; De Paula, V.J.R.; Forlenza, O.V. Mini Review: Mitochondrial Dysfunction in Alzheimer’s Disease: Therapeutic Implications of Lithium. Neurosci. Lett. 2021, 760, 136078. [Google Scholar] [CrossRef] [PubMed]
- Forlenza, O.V.; De-Paula, V.J.R.; Diniz, B.S.O. Neuroprotective Effects of Lithium: Implications for the Treatment of Alzheimer’s Disease and Related Neurodegenerative Disorders. ACS Chem. Neurosci. 2014, 5, 443–450. [Google Scholar] [CrossRef]
- Hajka, D.; Budziak, B.; Pietras, Ł.; Duda, P.; McCubrey, J.A.; Gizak, A. GSK3 as a Regulator of Cytoskeleton Architecture: Consequences for Health and Disease. Cells 2021, 10, 2092. [Google Scholar] [CrossRef]
- Chiu, C.-T.; Chuang, D.-M. Molecular Actions and Therapeutic Potential of Lithium in Preclinical and Clinical Studies of CNS Disorders. Pharmacol. Ther. 2010, 128, 281–304. [Google Scholar] [CrossRef]
- Nusse, R. Wnt Signaling in Disease and in Development. Cell Res. 2005, 15, 28–32. [Google Scholar] [CrossRef] [PubMed]
- De-Paula, V.J.; dos Santos, C.C.C.; Luque, M.C.A.; Ali, T.M.; Kalil, J.E.; Forlenza, O.V.; Cunha-Neto, E. Acute and Chronic Lithium Treatment Increases Wnt/β-Catenin Transcripts in Cortical and Hippocampal Tissue at Therapeutic Concentrations in Mice. Metab. Brain Dis. 2021, 36, 193–197. [Google Scholar] [CrossRef] [PubMed]
- Wilson, E.N.; Do Carmo, S.; Iulita, M.F.; Hall, H.; Ducatenzeiler, A.; Marks, A.R.; Allard, S.; Jia, D.T.; Windheim, J.; Cuello, A.C. BACE1 Inhibition by Microdose Lithium Formulation NP03 Rescues Memory Loss and Early Stage Amyloid Neuropathology. Transl. Psychiatry 2017, 7, e1190. [Google Scholar] [CrossRef] [PubMed]
- Fiorentini, A.; Rosi, M.C.; Grossi, C.; Luccarini, I.; Casamenti, F. Lithium Improves Hippocampal Neurogenesis, Neuropathology and Cognitive Functions in APP Mutant Mice. PLoS ONE 2010, 5, e14382. [Google Scholar] [CrossRef]
- Puglisi-Allegra, S.; Lazzeri, G.; Busceti, C.L.; Giorgi, F.S.; Biagioni, F.; Fornai, F. Lithium Engages Autophagy for Neuroprotection and Neuroplasticity: Translational Evidence for Therapy. Neurosci. Biobehav. Rev. 2023, 148, 105148. [Google Scholar] [CrossRef]
- Mendes, C.T.; Mury, F.B.; de Sá Moreira, E.; Alberto, F.L.; Forlenza, O.V.; Dias-Neto, E.; Gattaz, W.F. Lithium Reduces Gsk3b mRNA Levels: Implications for Alzheimer Disease. Eur. Arch. Psychiatry Clin. Neurosci. 2009, 259, 16–22. [Google Scholar] [CrossRef]
- Stanca, S.; Rossetti, M.; Bongioanni, P. Astrocytes as Neuroimmunocytes in Alzheimer’s Disease: A Biochemical Tool in the Neuron–Glia Crosstalk along the Pathogenetic Pathways. Int. J. Mol. Sci. 2023, 24, 13880. [Google Scholar] [CrossRef]
- Damri, O.; Agam, G. Lithium, Inflammation and Neuroinflammation with Emphasis on Bipolar Disorder-A Narrative Review. Int. J. Mol. Sci. 2024, 25, 13277. [Google Scholar] [CrossRef]
- Wilson, E.N.; Do Carmo, S.; Welikovitch, L.A.; Hall, H.; Aguilar, L.F.; Foret, M.K.; Iulita, M.F.; Jia, D.T.; Marks, A.R.; Allard, S.; et al. NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats. J. Alzheimer’s Dis. 2020, 73, 723–739. [Google Scholar] [CrossRef]
- Bora, E.; Fornito, A.; Yücel, M.; Pantelis, C. Voxelwise Meta-Analysis of Gray Matter Abnormalities in Bipolar Disorder. Biol. Psychiatry 2010, 67, 1097–1105. [Google Scholar] [CrossRef]
- Lyoo, I.K.; Dager, S.R.; Kim, J.E.; Yoon, S.J.; Friedman, S.D.; Dunner, D.L.; Renshaw, P.F. Lithium-Induced Gray Matter Volume Increase As a Neural Correlate of Treatment Response in Bipolar Disorder: A Longitudinal Brain Imaging Study. Neuropsychopharmacology 2010, 35, 1743–1750. [Google Scholar] [CrossRef] [PubMed]
- Ferensztajn-Rochowiak, E.; Chłopocka-Woźniak, M.; Rybakowski, J.K. Ultra-Long-Term Lithium Therapy: All-Important Matters and a Case of Successful 50-Year Lithium Treatment. Braz. J. Psychiatry 2020, 43, 407–413. [Google Scholar] [CrossRef]
- Kessing, L.V.; Gerds, T.A.; Knudsen, N.N.; Jørgensen, L.F.; Kristiansen, S.M.; Voutchkova, D.; Ernstsen, V.; Schullehner, J.; Hansen, B.; Andersen, P.K.; et al. Lithium in Drinking Water and the Incidence of Bipolar Disorder: A Nation-Wide Population-Based Study. Bipolar Disord. 2017, 19, 563–567. [Google Scholar] [CrossRef]
- Pan, Y.; Short, J.L.; Newman, S.A.; Choy, K.H.C.; Tiwari, D.; Yap, C.; Senyschyn, D.; Banks, W.A.; Nicolazzo, J.A. Cognitive Benefits of Lithium Chloride in APP/PS1 Mice Are Associated with Enhanced Brain Clearance of β-Amyloid. Brain Behav. Immun. 2018, 70, 36–47. [Google Scholar] [CrossRef] [PubMed]
- De-Paula, V.J.; Forlenza, O.V. Lithium Modulates Multiple Tau Kinases with Distinct Effects in Cortical and Hippocampal Neurons According to Concentration Ranges. Naunyn Schmiedebergs Arch. Pharmacol. 2022, 395, 105–113. [Google Scholar] [CrossRef]
- Manji, H.K.; Moore, G.J.; Chen, G. Lithium Up-Regulates the Cytoprotective Protein Bcl-2 in the CNS in Vivo: A Role for Neurotrophic and Neuroprotective Effects in Manic Depressive Illness. J. Clin. Psychiatry 2000, 61 (Suppl. S9), 82–96. [Google Scholar]
- Forlenza, O.V.; Diniz, B.S.; Radanovic, M.; Santos, F.S.; Talib, L.L.; Gattaz, W.F. Disease-Modifying Properties of Long-Term Lithium Treatment for Amnestic Mild Cognitive Impairment: Randomised Controlled Trial. Br. J. Psychiatry 2011, 198, 351–356. [Google Scholar] [CrossRef]
- Forlenza, O.V.; Radanovic, M.; Talib, L.L.; Gattaz, W.F. Clinical and Biological Effects of Long-Term Lithium Treatment in Older Adults with Amnestic Mild Cognitive Impairment: Randomised Clinical Trial. Br. J. Psychiatry 2019, 215, 668–674. [Google Scholar] [CrossRef]
- Hampel, H.; Ewers, M.; Bürger, K.; Annas, P.; Mörtberg, A.; Bogstedt, A.; Frölich, L.; Schröder, J.; Schönknecht, P.; Riepe, M.W.; et al. Lithium Trial in Alzheimer’s Disease: A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study. J. Clin. Psychiatry 2009, 70, 922–931. [Google Scholar]
- Danivas, V.; Moily, N.S.; Thimmaiah, R.; Muralidharan, K.; Purushotham, M.; Muthane, U.; Jain, S. Off Label Use of Lithium in the Treatment of Huntington’s Disease: A Case Series. Indian J. Psychiatry 2013, 55, 81–83. [Google Scholar] [CrossRef]
- UKMND-LiCALS Study Group; Morrison, K.E.; Dhariwal, S.; Hornabrook, R.; Savage, L.; Burn, D.J.; Khoo, T.K.; Kelly, J.; Murphy, C.L.; Al-Chalabi, A.; et al. Lithium in Patients with Amyotrophic Lateral Sclerosis (LiCALS): A Phase 3 Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial. Lancet Neurol. 2013, 12, 339–345. [Google Scholar] [CrossRef] [PubMed]
- Liaugaudaite, V.; Mickuviene, N.; Raskauskiene, N.; Naginiene, R.; Sher, L. Lithium Levels in the Public Drinking Water Supply and Risk of Suicide: A Pilot Study. J. Trace Elem. Med. Biol. 2017, 43, 197–201. [Google Scholar] [CrossRef] [PubMed]
- Fraiha-Pegado, J.; de Paula, V.J.R.; Alotaibi, T.; Forlenza, O.; Hajek, T. Trace Lithium Levels in Drinking Water and Risk of Dementia: A Systematic Review. Int. J. Bipolar Disord. 2024, 12, 32. [Google Scholar] [CrossRef]
- Müller-Oerlinghausen, B.; Lewitzka, U. Lithium Reduces Pathological Aggression and Suicidality: A Mini-Review. Neuropsychobiology 2010, 62, 43–49. [Google Scholar] [CrossRef]
- Lewitzka, U.; Severus, E.; Bauer, R.; Ritter, P.; Müller-Oerlinghausen, B.; Bauer, M. The Suicide Prevention Effect of Lithium: More than 20 Years of Evidence-a Narrative Review. Int. J. Bipolar Disord. 2015, 3, 32. [Google Scholar] [CrossRef] [PubMed]
- Devanand, D.P.; Crocco, E.; Forester, B.P.; Husain, M.M.; Lee, S.; Vahia, I.V.; Andrews, H.; Simon-Pearson, L.; Imran, N.; Luca, L.; et al. Low Dose Lithium Treatment of Behavioral Complications in Alzheimer’s Disease: Lit-AD Randomized Clinical Trial. Am. J. Geriatr. Psychiatry 2022, 30, 32–42. [Google Scholar] [CrossRef]
- Devanand, D.P.; Pelton, G.H.; D’Antonio, K.; Strickler, J.G.; Kreisl, W.C.; Noble, J.; Marder, K.; Skomorowsky, A.; Huey, E.D. Low-Dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series. Alzheimer Dis. Assoc. Disord. 2017, 31, 73–75. [Google Scholar] [CrossRef]
- Devanand, D.P.; Strickler, J.G.; Huey, E.D.; Crocco, E.; Forester, B.P.; Husain, M.M.; Vahia, I.V.; Andrews, H.; Wall, M.M.; Pelton, G.H. Lithium Treatment for Agitation in Alzheimer’s Disease (Lit-AD): Clinical Rationale and Study Design. Contemp. Clin. Trials 2018, 71, 33–39. [Google Scholar] [CrossRef]
- Damiano, R.F.; Loureiro, J.C.; Pais, M.V.; Pereira, R.F.; Corradi, M.D.M.; Santi, T.D.; Bezerra, G.A.M.; Radanovic, M.; Talib, L.L.; Forlenza, O.V. Revisiting Global Cognitive and Functional State 13 Years after a Clinical Trial of Lithium for Mild Cognitive Impairment. Braz. J. Psychiatry 2023, 45, 46–49. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Radanovic, M.; Singulani, M.P.; De Paula, V.d.J.R.; Talib, L.L.; Forlenza, O.V. An Overview of the Effects of Lithium on Alzheimer’s Disease: A Historical Perspective. Pharmaceuticals 2025, 18, 532. https://doi.org/10.3390/ph18040532
Radanovic M, Singulani MP, De Paula VdJR, Talib LL, Forlenza OV. An Overview of the Effects of Lithium on Alzheimer’s Disease: A Historical Perspective. Pharmaceuticals. 2025; 18(4):532. https://doi.org/10.3390/ph18040532
Chicago/Turabian StyleRadanovic, Marcia, Monique Patricio Singulani, Vanessa de Jesus R. De Paula, Leda Leme Talib, and Orestes Vicente Forlenza. 2025. "An Overview of the Effects of Lithium on Alzheimer’s Disease: A Historical Perspective" Pharmaceuticals 18, no. 4: 532. https://doi.org/10.3390/ph18040532
APA StyleRadanovic, M., Singulani, M. P., De Paula, V. d. J. R., Talib, L. L., & Forlenza, O. V. (2025). An Overview of the Effects of Lithium on Alzheimer’s Disease: A Historical Perspective. Pharmaceuticals, 18(4), 532. https://doi.org/10.3390/ph18040532